APA

Romanenko V., Osipova I., Galustyan A., Scherbakov M., Baudson N., Farhi D., Anaya L., Kuriyakose S. O., Meyer N. & Janssens W. (20210621). Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. : Human vaccines & immunotherapeutics.

Chicago

Romanenko Victor, Osipova Irina, Galustyan Anna, Scherbakov Michael, Baudson Nathalie, Farhi Déborah, Anaya Luis, Kuriyakose Sherine O, Meyer Nadia and Janssens Winnie. 20210621. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. : Human vaccines & immunotherapeutics.

Harvard

Romanenko V., Osipova I., Galustyan A., Scherbakov M., Baudson N., Farhi D., Anaya L., Kuriyakose S. O., Meyer N. and Janssens W. (20210621). Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. : Human vaccines & immunotherapeutics.

MLA

Romanenko Victor, Osipova Irina, Galustyan Anna, Scherbakov Michael, Baudson Nathalie, Farhi Déborah, Anaya Luis, Kuriyakose Sherine O, Meyer Nadia and Janssens Winnie. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. : Human vaccines & immunotherapeutics. 20210621.